Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Dow
Accenture
Novartis
Harvard Business School
Fuji
Queensland Health
Deloitte
Mallinckrodt
US Army

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,827,529

« Back to Dashboard

Summary for Patent: 5,827,529
Title: External preparation for application to the skin containing lidocaine
Abstract:An external preparation for application to the skin containing lidocaine which comprises a drug-retaining layer placed on a support, wherein said drug-retaining layer comprises an adhesive gel base and 1 to 10% by weight of lidocaine, said base comprising a water-soluble high molecular weight substance, water and a water-retaining agent, which can release the active lidocaine gradually and constantly so that lidocaine is transdermally absorbed for a long period of time.
Inventor(s): Ono; Masahiro (Kagawa-ken, JP), Akazawa; Mitsuji (Kagawa-ken, JP), Seki; Michiko (Kagawa-ken, JP), Iwamoto; Kiyomi (Kagawa-ken, JP), Konishi; Ryoji (Kagawa-ken, JP)
Assignee: Teikoku Seiyaku Kabushiki Kaisha (Kagawa-Ken, JP)
Application Number:08/258,378
Patent Claim Types:
see list of patent claims
Compound; Composition;

Drugs Protected by US Patent 5,827,529

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,827,529

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan3-067353Mar 30, 1991

International Patents Family Members for US Patent 5,827,529

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 149351 ➤ Sign Up
Canada 2064325 ➤ Sign Up
Germany 69217685 ➤ Sign Up
European Patent Office 0507160 ➤ Sign Up
Spain 2100970 ➤ Sign Up
Japan 3115625 ➤ Sign Up
Japan H04305523 ➤ Sign Up
Singapore 50517 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Cantor Fitzgerald
Fish and Richardson
Baxter
Julphar
Chubb
Johnson and Johnson
Merck
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot